Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 10860193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

  1998cited by this paper
• EasyMA: a program for the meta-analysis of clinical trials.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

  1996cited by this paper
• INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results.

  1995cited by this paper
• Prevention of diabetic renal disease with special reference to microalbuminuria.

  1995cited by this paper
• Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis.

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

  1991cited by this paper
• Excess mortality associated with diuretic therapy in diabetes mellitus.

  1991cited by this paper
• A general parametric approach to the meta-analysis of randomized clinical trials.

  1991cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

  1990cited by this paper
• Relation of ocular and systemic factors to survival in diabetes.

  1989cited by this paper
• Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion.

  1989cited by this paper
• The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

  1988cited by this paper
• Randomised trial of treatment of hypertension in elderly patients in primary care.

  1986cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• Metabolic consequences of antihypertensive therapy.

  1983cited by this paper
• Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

  1980cited by this paper
• Treatment of mild hypertension: results of a ten-year intervention trial.

  1977cited by this paper
• Hypotensive therapy in stroke survivors.

  1970cited by this paper
• Effects of treatment in hypertension. Results of a controlled study.

  1966cited by this paper

• Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology

  2024cites this paper
• Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment

  2020cites this paper
• Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure

  2019cites this paper
• Diabetes und Niere – nach vielen Jahren der Stagnation endlich Neuigkeiten?

  2019cites this paper
• Type 2 Diabetes and Thiazide Diuretics

  2018cites this paper
• Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME.

  2016cites this paper
• Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics.

  2016cites this paper
• Reduction in cardiovascular and all-cause mortality in the EMPA-REG OUTCOME trial: A critical analysis.

  2016cites this paper
• How individual participant data meta-analyses have influenced trial design, conduct, and analysis

  2015cites this paper
• Hypertension in Diabetes Mellitus

  2014cites this paper
• The COSEHC TM Global Vascular Risk Management quality improvement program : first follow-up report

  2013cites this paper
• The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report

  2013cites this paper
• What matters in ADVANCE and ADVANCE‐ON

  2012cites this paper
• Hypertension in the elderly: new and old evidence that treatment may benefit the old.

  2009cites this paper
• 14 – Prise en charge des diabétiques: l’enseignement des grandes études contrôlées

  2009cites this paper
• [Effective treatment of arterial hypertension in women reduces frequency of calls for medical aid due to emergency indications. Data from the AFINA study].

  2009cites this paper
• Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

  2008cites this paper
• The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

  2008cites this paper
• Diabetes mellitus in patients with coronary artery disease: cardiovascular risk assessment and impact of available treatments

  2008cites this paper
• New advances in treating patients with arterial hypertension and diabetes mellitus

  2007cites this paper
• Evaluation of the Dose Response With Valsartan and Valsartan/Hydrochlorothiazide in Patients With Essential Hypertension

  2007cites this paper
• Guías de práctica clínica sobre diabetes, prediabetes y enfermedades cardiovasculares

  2007cites this paper
• Tratamiento de la hipertensión arterial en los diabéticos: una revisión crítica

  2007cites this paper
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

  2007cites this paper
• ADVANCE: breaking new ground in type 2 diabetes

  2006cites this paper
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

  2006cites this paper
• Que nous apprennent les grands essais cliniques de prévention cardiovasculaire et rénale chez le malade diabétique de type 2 hypertendu

  2006cites this paper
• [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].

  2006cites this paper
• Meta-analysis of individual patient data from randomized trials: a review of methods used in practice

  2005cites this paper
• ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline

  2005cites this paper
• Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2005cites this paper
• ADVANCE: action in diabetes and vascular disease

  2005cites this paper
• The importance of blood pressure control in the patient with diabetes.

  2004cites this paper
• Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients

  2004cites this paper
• Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study

  2004cites this paper
• Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

  2003cites this paper
• The need for tighter control of cardiovascular risk factors in diabetic patients.

  2003cites this paper
• Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.

  2003cites this paper
• Evidence‐based treatment of hypertension in patients with diabetes mellitus

  2003cites this paper
• Diabetes and Vascular Disease: A New International Trial

  2003cites this paper
• Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?

  2003cites this paper
• [The kidney as a target organ in diabetic patients with arterial hypertension].

  2003cites this paper
• Are low target blood pressure goals justified in persons with diabetes mellitus?

  2003cites this paper
• Continuous quality control in diabetes care – implications

  2003cites this paper
• Guidelines for improving the care of the older person with diabetes mellitus.

  2003cites this paper
• Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

  2003cites this paper
• Beta-Blockers and Diabetes: The Bad Guys Come Good

  2002cites this paper
• Hypertension and diabetes

  2002cites this paper
• The epidemiology of end-stage renal disease among African Americans.

  2002cites this paper
• Race and kidney disease: the scope of the problem.

  2002cites this paper
• Blood pressure control—Effects on diabetic nephropathy progression: How low does blood pressure have to be?

  2002cites this paper
• Treating High Blood Pressure in Diabetes: The Evidence

  2002cites this paper
• Family physicians' and general practitioners' approaches to drug management of diabetic hypertension in primary care.

  2002cites this paper
• Blood Pressure Lowering In Diabetes: A Brief Review Of The Current Evidence And Description Of A New Trial

  2001cites this paper
• [Type 2 diabetes: what therapeutic strategy?].

  2001cites this paper
• Diabetics with Hypertension Not Controlled with ACE Inhibitors: Alternate Therapies

  2001cites this paper
• Combating diabetic nephropathy with drug therapy

  2001cites this paper
• Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

  2000cites this paper
• [Hypertension and diabetes].

  2000cites this paper
• Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

  1999cites this paper
• The kidney and hypertension in diabetes mellitus

  1989cites this paper